GSK and GSK:LN Related Headlines

Go Back

Mar 2, 2026 03:58AM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to INR17 at Morgan Stanley
Feb 20, 2026 03:30AM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to INR19 at Barclays
Feb 18, 2026 03:44AM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to INR20 at Berenberg
Feb 13, 2026 04:52AM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to INR1,900 at Deutsche Bank
Feb 9, 2026 04:03AM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to INR22.50 at Citi
Jan 27, 2026 01:55AM Citi Starts GlaxoSmithKline (GSK:LN) (GSK) at Neutral
Jan 16, 2026 04:58AM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP19.40 at UBS
Jan 16, 2026 04:50AM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to INR16.75 at Deutsche Bank
Jan 14, 2026 05:05AM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to INR16 at Morgan Stanley
Jan 7, 2026 02:38AM Barclays Downgrades GlaxoSmithKline (GSK:LN) (GSK) to Underweight
Nov 26, 2025 05:37AM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to INR16.60 at Berenberg
Nov 25, 2025 03:38AM BofA Securities Upgrades GlaxoSmithKline (GSK:LN) (GSK) to Neutral
Nov 4, 2025 04:39AM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to INR16 at Deutsche Bank
Oct 31, 2025 11:43PM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to INR21 at Jefferies
Oct 31, 2025 12:10PM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to INR19 at UBS
Oct 31, 2025 08:09AM Barclays Reiterates Equalweight Rating on GlaxoSmithKline (GSK:LN) (GSK)
Oct 25, 2025 04:09AM Deutsche Bank Reiterates Hold Rating on GlaxoSmithKline (GSK:LN) (GSK)
Sep 29, 2025 07:55AM UBS Reiterates Neutral Rating on GlaxoSmithKline (GSK:LN) (GSK)
Aug 4, 2025 02:33AM GlaxoSmithKline (GSK:LN) (GSK) PT Lowered to INR14 at JPMorgan
Jul 21, 2025 02:29AM GlaxoSmithKline (GSK:LN) (GSK) PT Lowered to INR12.90 at Morgan Stanley
Jun 30, 2025 11:58PM Deutsche Bank Reiterates Hold Rating on GlaxoSmithKline (GSK:LN) (GSK)
Jun 30, 2025 11:30AM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to INR15.80 at Goldman Sachs
Jun 24, 2025 08:09AM Deutsche Bank Reiterates Hold Rating on GlaxoSmithKline (GSK:LN) (GSK)

GSK and GSK:LN Related Press Releases

Go Back

GSK and GSK:LN Related SEC Filings

Go Back